Chemical Component Summary | |
---|---|
Name | Itacitinib |
Synonyms | 2-[1-[1-[3-fluoranyl-2-(trifluoromethyl)pyridin-4-yl]carbonylpiperidin-4-yl]-3-[4-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]ethanenitrile |
Identifiers | 2-[1-[1-[3-fluoranyl-2-(trifluoromethyl)pyridin-4-yl]carbonylpiperidin-4-yl]-3-[4-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]ethanenitrile |
Formula | C26 H23 F4 N9 O |
Molecular Weight | 553.514 |
Type | NON-POLYMER |
Isomeric SMILES | c1c[nH]c2c1c(ncn2)c3cnn(c3)C4(CN(C4)C5CCN(CC5)C(=O)c6ccnc(c6F)C(F)(F)F)CC#N |
InChI | InChI=1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35) |
InChIKey | KTBSXLIQKWEBRB-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 63 |
Chiral Atom Count | 0 |
Bond Count | 68 |
Aromatic Bond Count | 21 |
Drug Info: DrugBank
DrugBank ID | DB12154? |
---|---|
Name | Itacitinib |
Groups | investigational |
Description | Itacitinib has been used in trials studying the treatment of Melanoma, Carcinoma, Metastatic Cancer, Endometrial Cancer, and B-cell Malignancies, among others. |
Synonyms |
|
Categories |
|
ATC-Code | L04AA46 |
CAS number | 1334298-90-6 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 53380437 |
ChEMBL | CHEMBL3622820 |